A matrix for assessing whether AI systems meet governance duties and deliver value for purpose, people, profit and planet.
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Advances in analytical chemistry are improving food safety. From mass spectrometry to machine learning and biosensors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results